Company · CIK 1712641
Biofrontera AG
| CIK | 1712641 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | 2M |
| Business address | Germany |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2018-04-30 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-236021 | 2020-01-22 | 2022-03-11 | 4 | |
| 333-222546 | 2018-01-12 | 2018-02-15 | 8 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-03-11 | EFFECTDeclared effective | 333-236021 | 9999999995-22-000618 |
| 2021-02-25 | 424B5Shelf takedown | 333-236021 | 0001493152-21-004836 |
| 2020-02-18 | EFFECTDeclared effective | 333-236021 | 9999999995-20-000381 |
| 2020-01-22 | F-3Shelf registered | 333-236021 | 0001493152-20-000933 |
| 2018-02-15 | 424B4Final prospectus | 333-222546 | 0001615774-18-001233 |
| 2018-02-13 | EFFECTDeclared effective | 333-222546 | 9999999995-18-000430 |
| 2018-02-13 | F-1/AAmendment | 333-222546 | 0001615774-18-001079 |
| 2018-02-12 | F-1/AAmendment | 333-222546 | 0001615774-18-001003 |
| 2018-02-06 | F-1/AAmendment | 333-222546 | 0001615774-18-000863 |
| 2018-01-31 | F-1/AAmendment | 333-222546 | 0001615774-18-000718 |
| 2018-01-26 | F-1/AAmendment | 333-222546 | 0001615774-18-000575 |
| 2018-01-12 | F-1Registration filed | 333-222546 | 0001615774-18-000305 |
| 2017-10-04 | DRSDraft made public | 377-01737 | 0001615774-17-005545 |